News Page
Published March 24, 2025
After a US Congressman made shocking allegations against TransMedics, its stock price plunged 11%. Furious shareholders have now filed a class action lawsuit against the Company to recover their losses.
TransMedics manufactures devices necessary for cold transporting organs used in transplants.
In February 2024, Rep. Paul Gosar sent TransMedics a scathing letter accusing the Company of price-gouging and using coercive sales tactics. His letter said TransMedics’ extreme prices held the public “hostage” for life-saving technology.
Then, in January 2025, short seller Scorpion Capital published a research report confirming all of Gosar’s allegations. In fact, Scorpion said the situation was much worse, accusing TransMedics of “the most extreme and grotesque healthcare fraud” Scorpion had ever encountered.
Angry investors quickly dumped their shares after the Scorpion report. Some of those investors are now joining the class-action.